Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Intraclot Alteplase Injection an Option for Treating Lower Extremity DVT
Link ID 2808
Title Intraclot Alteplase Injection an Option for Treating Lower Extremity DVT
Url http://www.medscape.com/viewarticle/569381?src=rss
Description As an alternative to continuous-infusion thrombolytic regimens, direct intraclot injection of alteplase is a suitable treatment for deep vein thrombosis (DVT) of the lower extremity that limits systemic exposure to thrombolytic agents, new research indicates. Reuters Health Information
Category Articles > Pharmacists
Keywords
Date Jan 30, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Pharmacists
1. Vildagliptin Effective Monotherapy for Treatment-Naive Elderly Type 2 Diabetics
  The dipeptidyl peptidase IV inhibitor vildagliptin (Galvus) is effective monotherapy for treatment-naive elderly patients with type 2 diabetes, according to a report in the December issue of Diabetes Care. Reuters Health Information
Category:   Articles > Pharmacists


2. Weight-Loss Drug Rimonabant Increases Risk for Adverse Psychiatric Effects
  A meta-analysis of 4 randomized trials of the weight-loss drug rimonabant concurs with FDA findings of increased risk for adverse psychiatric effects.

Medscape Medical News
Category:   Articles > Pharmacists


3. Intravenous Dexamethasone Fails to Prevent Migraine Relapse
  In patients presenting to the emergency department for acute migraine, an intravenous dose of dexamethasone prior to discharge does not reduce the likelihood that they will suffer another headache in the next few days, according to a report in the March issue of Headache. Reuters Health Information
Category:   Articles > Pharmacists


4. Paroxysmal AF Carries Similar Risk of Stroke as Sustained AF
  A new analysis of an atrial fibrillation trial shows that patients with paroxysmal atrial fibrillation have similar risks for stroke and embolism as those with sustained atrial fibrillation. Medscape Medical News
Category:   Articles > Pharmacists


5. Urocortin 2 Induces Large Increases in LVEF and CO in Heart Failure
  The vasoactive peptide urocortin 2 (UCN2), a member of the corticotropin-releasing factor (CRF) peptide family, increases left ventricular ejection fraction (LVEF) nearly 15%, researchers report in the November issue of the European Heart Journal. Reuters Health Information
Category:   Articles > Pharmacists




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS